Samalin Investment Counsel’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-889
Closed -$212K 292
2023
Q1
$212K Hold
889
0.13% 219
2022
Q4
$220K Buy
+889
New +$216K 0.14% 209
2022
Q1
Sell
-1,157
Closed -$308K 269
2021
Q4
$308K Buy
1,157
+2
+0.2% +$510 0.18% 164
2021
Q3
$286K Buy
1,155
+109
+10% +$28K 0.19% 173
2021
Q2
$258K Sell
1,046
-14
-1% -$3.35K 0.17% 190
2021
Q1
$242K Buy
+1,060
New +$243K 0.16% 193
2020
Q1
Sell
-240
Closed -$46K 502
2019
Q4
$46K Buy
+240
New +$43K 0.04% 293

Other funds holding VHT

Samalin Investment Counsel's VHT Position: Q2 2023 in Review

Samalin Investment Counsel sold out of Vanguard Health Care ETF (VHT) in Q2 2023, closing a stake of 889 shares — an estimated $212K sold.

Samalin Investment Counsel first reported a position in VHT in Q4 2019 and held it in 7 quarters. The position peaked at $308K in Q4 2021. 923 funds tracked by Wall St. Rank hold VHT as of Q2 2023.

  • Samalin Investment Counsel reported no remaining Vanguard Health Care ETF position as of Q2 2023 after selling out during the quarter.
  • Samalin Investment Counsel sold 889 Vanguard Health Care ETF shares in Q2 2023, an estimated $212K.
  • Samalin Investment Counsel first reported a position in Vanguard Health Care ETF in Q4 2019 and held it in 7 quarters.
  • Samalin Investment Counsel's Vanguard Health Care ETF position peaked at $308K in Q4 2021.
  • 923 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2023.

Based on Samalin Investment Counsel's 13F filing for Q2 2023, filed 3 Aug 2023.